FDA Guideline: Post-Market Surveillance, MDR Reporting & Corrections/Removals
Digital tools and dashboards for trending device complaints and incidents
Digital Tools and Dashboards for Trending Device Complaints and Incidents Introduction to Post-Market Surveillance The post-market surveillance (PMS) of medical devices is a critical aspect of regulatory compliance and safety management. It pertains to the ongoing monitoring of devices after they have been approved for market use. With advancements in technology, regulatory bodies like the US FDA have emphasized the need for robust systems to constantly evaluate device performance, monitor adverse events, and detect trends related to complaints and incidents. This tutorial aims to provide regulatory and quality professionals with a comprehensive understanding of digital tools and dashboards that can…
Risk assessment methodologies for device incidents and near misses
Risk assessment methodologies for device incidents and near misses Risk Assessment Methodologies for Device Incidents and Near Misses The post-market landscape for medical devices presents numerous challenges, particularly surrounding device incidents and near misses. Regulatory professionals must diligently navigate the frameworks established by the FDA and other global organizations to ensure compliance and safeguard public health. This comprehensive guide will walk through the risk assessment methodologies applicable to these situations, including the relevant FDA regulations and practical applications. Understanding Post-Market Surveillance Regulations Post-market surveillance is a crucial component of medical device regulation aimed at monitoring the safety and effectiveness of…
Post market surveillance frameworks for US medical device manufacturers
Introduction to Post Market Surveillance Frameworks for Medical Devices In the rapidly evolving landscape of healthcare technology, post-market surveillance (PMS) plays a pivotal role in ensuring the safety and effectiveness of medical devices once they are on the market. For US medical device manufacturers, understanding the regulatory requirements surrounding PMS, particularly under the auspices of the US Food and Drug Administration (FDA), is essential for compliance, risk management, and maintaining public trust. This article serves as a comprehensive guide for regulatory affairs, quality assurance, clinical, and RA/QA professionals involved with medical devices and combination products, detailing the frameworks that govern…
Medical device reporting MDR requirements and timelines under 21 CFR 803
Medical Device Reporting MDR Requirements and Timelines under 21 CFR 803 The regulation and oversight of medical devices in the United States is critical to ensuring safety and effectiveness. The post-market phase involves rigorous monitoring and reporting protocols, particularly under the Medical Device Reporting (MDR) regulations as set forth in 21 CFR 803. This article serves as a comprehensive step-by-step tutorial for regulatory, quality, clinical, and RA/QA professionals involved in post-market surveillance of medical devices and combination products. Understanding the Basics of MDR Requirements The MDR regulations under 21 CFR 803 specify the requirements for manufacturers, importers, and device user…
When field corrections and removals must be reported to FDA
When Field Corrections and Removals Must Be Reported to FDA Understanding the landscape of field corrections and removals of medical devices is crucial for regulatory, quality, clinical, and RA/QA professionals. This guide aims to provide a comprehensive explanation of the requirements under the FDA’s regulations, especially 21 CFR 803, concerning post-market surveillance, Medical Device Reporting (MDR), and the necessary steps to ensure compliance when issues arise. 1. Introduction to Field Corrections and Removals Field corrections and removals refer to actions taken to address issues that affect the safety or effectiveness of a medical device once it has been distributed. According…